Cargando…
Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm (MPN) characterized by clonal myeloproliferation, progressive bone marrow (BM) fibrosis, splenomegaly, and anemia. BM fibrosis was previously thought to be a reactive phenomenon induced by mesenchymal stromal cells that are stimulated by t...
Autores principales: | Ozono, Yoshinori, Shide, Kotaro, Kameda, Takuro, Kamiunten, Ayako, Tahira, Yuki, Sekine, Masaaki, Akizuki, Keiichi, Nakamura, Kenichi, Iwakiri, Hisayoshi, Sueta, Mitsue, Hidaka, Tomonori, Kubuki, Yoko, Yamamoto, Shojiro, Hasuike, Satoru, Sawaguchi, Akira, Nagata, Kenji, Shimoda, Kazuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862060/ https://www.ncbi.nlm.nih.gov/pubmed/32472085 http://dx.doi.org/10.1038/s41375-020-0880-3 |
Ejemplares similares
-
Fibrocytes in primary myelofibrosis
por: Shimoda, Kazuya, et al.
Publicado: (2021) -
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
por: Shide, Kotaro, et al.
Publicado: (2019) -
Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
por: Kubuki, Yoko, et al.
Publicado: (2017) -
Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms
por: Kameda, Takuro, et al.
Publicado: (2015) -
Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
por: Shide, K, et al.
Publicado: (2017)